CS218027B1 - Method of making the ureidopenicilline - Google Patents
Method of making the ureidopenicilline Download PDFInfo
- Publication number
- CS218027B1 CS218027B1 CS671781A CS671781A CS218027B1 CS 218027 B1 CS218027 B1 CS 218027B1 CS 671781 A CS671781 A CS 671781A CS 671781 A CS671781 A CS 671781A CS 218027 B1 CS218027 B1 CS 218027B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- ampicillin
- imidazolidinone
- methylene chloride
- solution
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 19
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 16
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 241000219198 Brassica Species 0.000 claims 1
- 235000003351 Brassica cretica Nutrition 0.000 claims 1
- 235000003343 Brassica rupestris Nutrition 0.000 claims 1
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical group ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 235000010460 mustard Nutrition 0.000 claims 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 9
- 229960000723 ampicillin Drugs 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- -1 ampicillin triethylammonium salt Chemical class 0.000 description 2
- 229960003311 ampicillin trihydrate Drugs 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229960003623 azlocillin Drugs 0.000 description 2
- JTWOMNBEOCYFNV-NFFDBFGFSA-N azlocillin Chemical compound N([C@@H](C(=O)N[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C=1C=CC=CC=1)C(=O)N1CCNC1=O JTWOMNBEOCYFNV-NFFDBFGFSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229940056360 penicillin g Drugs 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- XBNGYFFABRKICK-UHFFFAOYSA-N 2,3,4,5,6-pentafluorophenol Chemical compound OC1=C(F)C(F)=C(F)C(F)=C1F XBNGYFFABRKICK-UHFFFAOYSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229910052731 fluorine Chemical group 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- YPBATNHYBCGSSN-VWPFQQQWSA-N mezlocillin Chemical compound N([C@@H](C(=O)N[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C=1C=CC=CC=1)C(=O)N1CCN(S(C)(=O)=O)C1=O YPBATNHYBCGSSN-VWPFQQQWSA-N 0.000 description 1
- 229960000198 mezlocillin Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000019371 penicillin G benzathine Nutrition 0.000 description 1
- IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachloro-phenol Natural products OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Vynález se týká způsobu výroby ureidopenicilinů obeoného vzorce I c CH. /S\/ 3 sťy-CHCONH-CH-CH C-^CH L H i ii i 3 The invention relates to a process for the production of ureidopenicillins of the formula I c CH. ( S ) / 3 S-CHCONH-CH-CHC-CH 2 H III 3
I CO-N —CHCOOHCO-N — CHCOOH
NH ONH O
I X co< nr L 1 (/) ve kterém R značí atom vodíku nebo methansulfonylskupinu.IX as <n r 1 L (/) in which R is hydrogen or methanesulfonyl.
Ureidoipeniciliny, mezi které patří například klinicky užívané preparáty azlocilin a mezlocilin, představují skupinu polosyntetiokých antibiotik, odvozených od aminopenicilinů, zejména ampicilinu. Mají rozšířené antimikrobiální spektrum, doplněné zejména u azocilinu o antipseudomonádovou účlnnost.Ureidoipenicillins, such as the clinically used formulations of azlocilin and meslocilin, represent a class of semi-synthetic thiotic antibiotics derived from aminopenicillins, particularly ampicillin. They have an extended antimicrobial spectrum, supplemented especially with azocillin by antipseudomonadic activity.
Známý způsob přípravy těchto antibiotik spočívá obvykle v acylací ampicilinu N-karbonylchloridem 2-imidazolidinonu. O této látce, která je produktem fosgenace ethylenmločoviny, tj. 2-imidazolidinonu, je známo, že reaguje s mnoha organickými roz2 pouštědly, dále že obsahuje nečistoty ve formě vedlejších produktů, například produktu vznikajícího· reakcí enolformy ethylenmiočoviny s fosgenem, jenž nereaguje žádaným směrem. Kromě toho má tato látka dráždivě účinky, po čase se rozkládá vzdušnou vlhkostí a uvolňuje plynný chlorovodík, takže práce s ní je velmi· nepříjemná, zdraví škodlivá a vyžaduje mimořádná bezpečnostní opatření.A known method for preparing these antibiotics usually consists in acylating ampicillin with 2-imidazolidinone N-carbonyl chloride. This substance, which is the product of the phosgenation of ethylene-urea, ie 2-imidazolidinone, is known to react with many organic solvents, further containing impurities in the form of by-products, for example the product resulting from the reaction of ethylene urea enolform with phosgene . In addition, this substance has an irritating effect, decomposes over time with air humidity and releases hydrogen chloride gas, so that it is very unpleasant, harmful to health and requires extraordinary safety precautions.
Uvedené nedostatky odstraňuje způsob výroby ureidopenicilinů obecného vzorce I podle vynálezu, při němž není nutno používat uvedeného agresivního činidla. Podstata způsobu podle vynálezu spočívá v tc-m, že se ampicilin ve formě soli s organickou terciární bází, s výhodou s triethylaminem, acyluje esterem N-karbonyl-2-imidazolidinonu obecného vzorce IIThese drawbacks are overcome by the process for the preparation of the ureidopenicillins of the general formula (I) according to the invention, without the use of the aggressive agent. The process according to the invention is characterized in that ampicillin in the form of a salt with an organic tertiary base, preferably triethylamine, is acylated with an ester of N-carbonyl-2-imidazolidinone of the formula II
X X tf-N^NCOO-VT-X í Vf X X (II) aXX tf-N ^ NCOO-VT-X i Vf XX (II) a
ve kterém X značí atom chloru nebo fluoru a R totéž co ve vzorci I, v prostředí netečného organického rozpouštědla typu halogenovaného alikanu s 1 až 2 atomy uhlíku, s výhodou methylenchloridu.in which X is a chlorine or fluorine atom and R is the same as in formula I in an inert inert solvent of the halogenated C1-C2-alkane type, preferably methylene chloride.
Estery obecného vzorce II jsou dobře identiifikoivatelná a charakterízovatelná chemická individua, snadno přístupná reakcí N-karbonylchlorid-2-imidazolinu s penitachlor- nebo pentafluorfenolem. Hladkou reakcí s ampicilinem poskytují ureidopeniciliny azocilin a mezlocilin v dobrém1 výtěžku a vysoké čistotě, bez dřívějších nepříjemných komplikací.The esters of formula (II) are well identifiable and characterizable chemical individuals, readily accessible by reaction of N-carbonyl chloride-2-imidazoline with penitachloro- or pentafluorophenol. Smooth reaction to give ampicillin and mezlocillin ureidopeniciliny azocilin 1 in good yield and high purity, without previous unpleasant complications.
Bližší podrlobnosti způsobu podle vynálezu vyplývají z následujících příkladů provedení, které tento způsob -pouze Ilustrují, ale nijak neomezují.The details of the method according to the invention are illustrated by the following examples, which are illustrative but not limiting.
Příklad 1Example 1
1,0 g žádaného produktu, který je identický s azlocililnem, t. t. 168 až 170 °C.1.0 g of the desired product, which is identical to azlocillin, m.p. 168-170 ° C.
Příklad 2Example 2
D-a-(l-imldazolidin-2-Gn-l-ylkarb ony lamino ) -benzylpenicilin (azlocilin)D-α- (1-Imldazolidin-2-Gn-1-ylcarbonylamino) -benzylpenicillin (azlocillin)
K roztoku triethylamloniové soli ampicilinu, získanému z 1,7 g trihydrátu ampicilinu a 1,Q1 g triethylaminu ve 20 ml bezvodého methylenchloridu, se přidají 2,06 g 1-karbonylpentachlorfenoxy-2-imidazolidinonu a vzniklá suspenze se míchá při teplotě místnosti po dlobu 48 hodin. Reakční směs se potom protřepe 20 ml vody, vyčiří aktivním uhlím, zfiltruje a filtrát se okyselí. Získá seTo a solution of ampicillin triethylammonium salt obtained from 1.7 g ampicillin trihydrate and 1.0 g triethylamine in 20 ml anhydrous methylene chloride was added 2.06 g 1-carbonylpentachlorophenoxy-2-imidazolidinone and the resulting suspension was stirred at room temperature for 48 hours. hours. The reaction mixture is then shaken with 20 ml of water, clarified with charcoal, filtered and the filtrate acidified. It is obtained
D-a-[,(3-methansulfonylimidazolidln-2-on-l-yl j -karbonylamino] benzylpenicilinD-a - [, (3-methanesulfonylimidazolidin-2-one-1-yl) -carbonylamino] benzylpenicillin
a) K roztoku triethylamoniové soli ampicilinu, připravenému z 1,2 g trihydrátu ampicilinu a 0,6 g triethylaminu ve 20 ml methylenchloridu, se přidá 1,1 g 1-karbonylpentafluorfeinoxy-Í3-methansulfonyl-2-imidázolidinonu, přičemž okamžitě vznikne čirý rioztok. Po 2 h stání se roztok extrahuje 3ikrát po 10 ml vody, vodné výtřepky se spojí, zfiltrují a zbaví zbytků methylenchloridu. Hodnota1 pH tohoto vodného roztoku se upraví přídavkemi zředěné kyseliny chlorovodíkové na 2,5, vyloučený krystalický produkt se odsaje, promyje vodou a vysuší. Získá se 1,1 g mezlocilinu identicikého s autentickým vzorkem.(a) To a solution of the triethylammonium salt of ampicillin prepared from 1,2 g of ampicillin trihydrate and 0,6 g of triethylamine in 20 ml of methylene chloride, 1,1 g of 1-carbonylpentafluorpheinoxy-β-methanesulfonyl-2-imidazolidinone is added immediately giving a clear solution . After standing for 2 h, the solution is extracted 3 times with 10 ml of water each time, the aqueous extracts are combined, filtered and freed of methylene chloride residues. Value 1 The pH of this aqueous solution is adjusted by adding dilute hydrochloric acid to 2.5, the crystalline product is sucked off, washed with water and dried. 1.1 g of meslocillin identical to the authentic sample are obtained.
b) K roztoku triethylamoniové stolí ampicilinu, připravenému z 1,74 g bezvodého ampicilinu a 1,01 g triethylaminu ve 20 ml methylenchloridu, se přidá roztok 2,5 g 1-karbomylpentachlorfenoxy-3-methansulfionyl-2-imidazolidinonn v malém množství methylenchloridu. Reakční směs se míchá při teplotě místnosti 6 h a zpracuje se jako v odstavci aj. Získá se 1,4 g mezlocilinu to teplotě rozkladu 155 až 165 °C.b) To a solution of triethylammonium ampicillin table, prepared from 1.74 g of anhydrous ampicillin and 1.01 g of triethylamine in 20 ml of methylene chloride, was added a solution of 2.5 g of 1-carbomylpentachlorophenoxy-3-methanesulfionyl-2-imidazolidinone in a small amount of methylene chloride. The reaction mixture was stirred at room temperature for 6 h and treated as in paragraph a. 1.4 g of meslocillin at a decomposition temperature of 155-165 ° C were obtained.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS671781A CS218027B1 (en) | 1981-09-11 | 1981-09-11 | Method of making the ureidopenicilline |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS671781A CS218027B1 (en) | 1981-09-11 | 1981-09-11 | Method of making the ureidopenicilline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS218027B1 true CS218027B1 (en) | 1983-02-25 |
Family
ID=5414852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS671781A CS218027B1 (en) | 1981-09-11 | 1981-09-11 | Method of making the ureidopenicilline |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS218027B1 (en) |
-
1981
- 1981-09-11 CS CS671781A patent/CS218027B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101379025B (en) | Improved preparation of nitroisourea derivatives | |
| KR100342944B1 (en) | Method for preparing highly pure cefpodoxime proxetil | |
| CS218027B1 (en) | Method of making the ureidopenicilline | |
| KR100674098B1 (en) | Process for preparing N-alk (en) oxy (or aryloxy) carbonylisothiocyanate and derivatives thereof in the presence of N, N-dialkylarylamine catalyst | |
| US5525730A (en) | Processes for preparation of sulfonylurea derivatives | |
| JP3919215B2 (en) | Process for producing carboxyarene sulfonic acid and its carboxylic acid derivative | |
| CN110950836B (en) | A kind of preparation method of benzodithiocyclopentene skeleton compound | |
| US3869509A (en) | N-alkyl-N(trihalomethylthio)-sulfamic acid chloride | |
| SU1371490A3 (en) | Defoliation agent | |
| JP4879907B2 (en) | Process for producing phenyl 2-pyrimidinyl ketones and novel intermediates thereof | |
| US5525729A (en) | Benz-1,2,3-oxathiazin-4(3F)-one-2,2-dioxides, a process for their preparation and their use as electrophilic fluorinating agents | |
| JPH0439464B2 (en) | ||
| WO1998046568A1 (en) | Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof | |
| US4232162A (en) | P-Substituted N,N'-bis-(3-oxazolidinyl-2-one)phosphoramides and process for the preparation thereof | |
| EP0079991B1 (en) | Method for making thiobiscarbamates | |
| CA1238632A (en) | Preparation of 1'-ethoxycarbonyloxyethyl esters of penicillins and novel intermediates | |
| KR100406632B1 (en) | Novel process for preparing thrombin inhibitor | |
| JP2540391B2 (en) | Process for producing β-ketoester | |
| JP2540390B2 (en) | Method for producing β-keto ester | |
| JPS62175492A (en) | Production of n-phosphinothioylamine derivative | |
| KR100498894B1 (en) | Process for producing 1-chlorocarbonyl-4-piperidino- piperidine or hydrochloride thereof | |
| KR960015005B1 (en) | Method for preparing sulfonylurea derivative | |
| KR960010101B1 (en) | Manufacturing method of 4-ortho toryl thiemicarbazide | |
| KR970006853B1 (en) | 1-££(pyrazolsulfonyl)amino| carbonyl| pyridinium hydroxide and process for the preparation thereof | |
| KR900006446B1 (en) | Process for the preparation of urea derivatives |